UN

Uni-Bio Science Group Ltd

Develops biopharma therapies for endocrinology, ophthalmology, and dermatology needs.

690 | HKEX

Overview

Corporate Details

ISIN(s):
KYG9198H1406
LEI:
Country:
Hong Kong
Address:
N/A
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Uni-Bio Science Group Ltd. is an integrated biopharmaceutical company focused on the research, development, manufacturing, and commercialization of innovative therapies. The company's core research areas include endocrinology (such as diabetes and osteoporosis), ophthalmology (addressing conditions like dry eye and corneal injury), and dermatology, including medical aesthetics and wound healing. Uni-Bio Science operates across four integrated technology platforms: new drug research, clinical development, production and quality control, and commercial sales. Its pipeline features a differentiated portfolio of biological and chemical drugs, including proprietary treatments like Bogutai® and Uni-GLP-1, as well as cosmetic peptides and stem cell exosomes, aiming to address significant unmet medical needs and improve patient quality of life.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Uni-Bio Science Group Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Uni-Bio Science Group Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Uni-Bio Science Group Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CEL SCI CORP Logo
Develops immunotherapies for cancer, autoimmune, and infectious diseases.
United States of America
CVM
Celularity Inc Logo
Develops off-the-shelf cell therapies from placentas for cancer and aging-related diseases.
United States of America
CELU
Centessa Pharmaceuticals plc Logo
Develops medicines for sleep-wake disorders, hemophilia, and other unmet medical needs.
United States of America
CNTA
CERO THERAPEUTICS HOLDINGS, INC. Logo
Develops engineered T-cell immunotherapies for cancer using its proprietary CER platform.
United States of America
CERO
CervoMed Inc. Logo
Developing CNS therapeutics for neurodegenerative diseases like dementia with Lewy bodies.
United States of America
CRVO
Cessatech A/S Logo
Develops a non-invasive nasal spray for acute pain relief in children during medical procedures.
Denmark
CESSA
CG Invites Co., Ltd. Logo
Biopharma advancing precision medicine with drugs, mRNA vaccines, and digital therapeutics.
South Korea
083790
CG Oncology, Inc. Logo
Developing bladder-sparing oncolytic immunotherapies for patients with bladder cancer.
United States of America
CGON
CHA Vaccine Research Institute Logo
Develops vaccines and immunotherapies for infectious diseases and cancer using proprietary platforms.
South Korea
261780
Manufactures veterinary medicines and feed additives for livestock, aquatic animals, and pets.
South Korea
052670

Talk to a Data Expert

Have a question? We'll get back to you promptly.